Related Experiment Video
Updated: Jul 20, 2026

The Use of Thermal Infra-Red Imaging to Detect Delayed Onset Muscle Soreness
Published on: January 22, 2012
Effects of different negative pressure cupping interventions on inflammatory response and motor function recovery in
Xu Song1, Teng Ma2, XianYou Cui1
1School of Physical Education, Zhejiang Guangsha Vocational and Technical University of Construction, Dongyang, China.
Introduction:
This study examined the impacts of different negative pressure cupping therapies (NPCT) on pain relief, functional recovery, and inflammatory regulation in delayed onset muscle soreness (DOMS) after high-intensity exercise, with the aim of clarifying the dose-effect relationship.
Methods:
In this study, 55 healthy male participants aged 18-25 were selected and divided into 5 groups: the control group (CTR; n = 11) and NPCT groups at different levels (-25 kPa, -35 kPa, -45 kPa, and -55 kPa; n = 11 in each group). A high-intensity protocol, which included 6 sets of lunges, squats, and squat jumps, was adopted to induce DOMS in the quadriceps femoris. Immediately after the exercise, the DGN-6 vacuum device was used for a 10 min NPCT treatment. The research outcomes included visual analog scale (VAS) pain scores, lower extremity explosive strength tests (30-meter sprint and standing long jump), joint range of motion (ROM), and serum biomarkers [CK, LDH, and inflammatory cytokines (IL-6, TNF-α, and Hsp27)]. These were assessed at the baseline and 24 h after the intervention.
Results:
NPCT groups exhibited significantly lower VAS scores than the CTR group (-55 kPa: 1.57 ± 0.79 vs. 6.14 ± 0.69; P < 0.05), and the efficacy was pressure-dependent (-55 kPa > -4 kPa > -35 kPa; P < 0.01). Functional recovery was significantly improved in NPCT groups (30-meter sprint: 0.27 s; standing long jump: 0.08 m; P < 0.01). Knee ROM increased by 5.71° at -55 kPa and 6.43° at -45 kPa (P < 0.05). Biochemically, CK/LDH levels normalized in -45 kPa and -55 kPa groups (P < 0.05). Meanwhile, the levels of IL-6 and TNF-α decreased significantly (P < 0.05), and these changes were correlated with Hsp27 expression (r = 0.42-0.49; P < 0.05).
Discussion:
These findings demonstrate that NPCT at pressures ranging from -45 kPa to -55 kPa is most effective in alleviating DOMS by enhancing hemodynamics and modulating the anti-inflammatory response, which supports its integration into post-exercise rehabilitation protocols.
Clinical Trial Registration:
https://www.chictr.org.cn/showprojEN.html?proj=263241, Chinese Clinical Trial Registry (ChiCTR) (Registration NO.: ChiCTR- 2500098071, 03/03/2025).
More Related Videos
07:49Application of Consistent Massage-Like Perturbations on Mouse Calves and Monitoring the Resulting Intramuscular Pressure Changes
Published on: September 20, 2019
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Related Concept Videos
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...